Efficacy and Safety of Metreleptin in Patients with Partial Lipodystrophy: Lessons from an Expanded Access Program.
about
Shortcuts to a functional adipose tissue: The role of small non-coding RNAs.Adipose tissue: between the extremes.Long Distance Metabolic Regulation through Adipose-Derived Circulating Exosomal miRNAs: A Trail for RNA-Based Therapies?Facial soft tissue volume decreases during metreleptin treatment in patients with partial and generalized lipodystrophy.Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort."Fat Shadows" From DXA for the Qualitative Assessment of Lipodystrophy: When a Picture Is Worth a Thousand Numbers
P2860
Efficacy and Safety of Metreleptin in Patients with Partial Lipodystrophy: Lessons from an Expanded Access Program.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and Safety of Metrele ...... om an Expanded Access Program.
@en
Efficacy and Safety of Metrele ...... om an Expanded Access Program.
@nl
type
label
Efficacy and Safety of Metrele ...... om an Expanded Access Program.
@en
Efficacy and Safety of Metrele ...... om an Expanded Access Program.
@nl
prefLabel
Efficacy and Safety of Metrele ...... om an Expanded Access Program.
@en
Efficacy and Safety of Metrele ...... om an Expanded Access Program.
@nl
P2093
P2860
P1476
Efficacy and Safety of Metrele ...... om an Expanded Access Program.
@en
P2093
Adam H Neidert
Elif A Oral
Moahad Dar
Nevin Ajluni
P2860
P356
10.4172/2155-6156.1000659
P577
2016-03-23T00:00:00Z